The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment
- PMID: 34622165
- PMCID: PMC8479790
- DOI: 10.1016/j.isci.2021.103112
The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment
Abstract
The kidney local microenvironment (KLM) plays a critical role in the pathogenesis of kidney fibrosis. However, the composition and regulation of a fibrotic KLM remain unclear. Through a multidisciplinary approach, we investigated the roles of the hepatocyte growth factor/c-met signaling pathway in regulating KLM formation in various chronic kidney disease (CKD) models. We performed a retrospective analysis of single-cell RNA sequencing data and determined that tubular epithelial cells and macrophages are two major cell populations in a fibrotic kidney. We then created a mathematical model that predicted loss of c-met in tubular cells would cause greater responses to injury than loss of c-met in macrophages. By generating c-met conditional knockout mice, we validated that loss of c-met influences epithelial plasticity, myofibroblast activation, and extracellular matrix synthesis/degradation, which ultimately determined the characteristics of the fibrotic KLM. Our findings open the possibility of designing effective therapeutic strategies to retard CKD.
© 2021 The Authors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![None](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/fx1.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8479790/bin/gr7.gif)
Similar articles
-
Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.Biochim Biophys Acta. 2012 Jun;1822(6):942-51. doi: 10.1016/j.bbadis.2012.02.012. Epub 2012 Feb 22. Biochim Biophys Acta. 2012. PMID: 22386877 Free PMC article.
-
Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling.Kidney Int. 2020 May;97(5):1017-1031. doi: 10.1016/j.kint.2020.01.026. Epub 2020 Feb 17. Kidney Int. 2020. PMID: 32245660 Free PMC article.
-
Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction.Kidney Int. 2009 Oct;76(8):868-76. doi: 10.1038/ki.2009.304. Epub 2009 Aug 12. Kidney Int. 2009. PMID: 19675527
-
Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells.Curr Opin Nephrol Hypertens. 2003 Jan;12(1):25-9. doi: 10.1097/00041552-200301000-00005. Curr Opin Nephrol Hypertens. 2003. PMID: 12496662 Review.
-
Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation.Adv Exp Med Biol. 2019;1165:253-283. doi: 10.1007/978-981-13-8871-2_12. Adv Exp Med Biol. 2019. PMID: 31399969 Review.
Cited by
-
Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injury.Int J Biol Sci. 2023 May 29;19(9):2860-2878. doi: 10.7150/ijbs.82417. eCollection 2023. Int J Biol Sci. 2023. PMID: 37324945 Free PMC article.
-
Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis.Mol Metab. 2023 May;71:101712. doi: 10.1016/j.molmet.2023.101712. Epub 2023 Mar 22. Mol Metab. 2023. PMID: 36963615 Free PMC article.
-
Editorial: Tissue microenvironment in kidney diseases.Front Med (Lausanne). 2023 Feb 6;10:1134043. doi: 10.3389/fmed.2023.1134043. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36814777 Free PMC article. No abstract available.
References
-
- Anders H.J., Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 2011;80:915–925. - PubMed
-
- Baricos W.H., Cortez S.L., el-Dahr S.S., Schnaper H.W. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int. 1995;47:1039–1047. - PubMed
-
- Chang-Panesso M., Humphreys B.D. Cellular plasticity in kidney injury and repair. Nat. Rev. Nephrol. 2017;13:39–46. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous